Literature DB >> 17024503

Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women.

M Lefevre-Pettazzoni1, S Le Cam, M Wallon, F Peyron.   

Abstract

The low avidity of immunoglobulin G has been reported to be a useful marker of recent infection with Toxoplasma. Several investigators, however, have published discrepant result on the maturation of avidity over time. The aim of this study was to analyse persistent low avidity of immunoglobulin G in immunocompetent individuals and in pregnant women and how it could interfere in the flowchart of antenatal diagnosis of toxoplasmosis in the latter group. An international literature search was conducted together with a retrospective study of a hospital database. Eleven publications that met the inclusion criteria reported delayed maturation of avidity at a frequency ranging from 0 to 66.6% of the patients. Examination of those publications demonstrated an important heterogeneity in the type of assay used, the calculation of avidity, the cutoff above which avidity was considered to be elevated, and the delay since infection after which indices are expected to be high. In the hospital database, persistent low avidity was found even after a median follow-up period of 6 years. Different factors could interfere with maturation of avidity, such as variations between individuals, the assay system used, and, possibly, the treatment administered. The results of this study clearly demonstrate that, in a pregnant woman, an acute infection cannot be reliably diagnosed solely on the basis of low avidity of immunoglobulin G. Further investigations and standardization of assays are urgently needed. Estimation of the time of infection remains difficult, especially in cases in which the samples are drawn late in pregnancy; the final estimate must be based on several tests repeated at intervals of weeks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024503     DOI: 10.1007/s10096-006-0204-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Dissecting the IgM antibody response during the acute and latent phase of toxoplasmosis.

Authors:  B Meek; T van Gool; H Gilis; R Peek
Journal:  Diagn Microbiol Infect Dis       Date:  2001-11       Impact factor: 2.803

2.  Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy.

Authors:  A E Ades
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

3.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  DOT-enzyme-linked immunosorbent assay (DOT-ELISA) for evaluating IgG antibody avidity in toxoplasmosis.

Authors:  F G Melo; C L Rossi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1997 Jul-Aug       Impact factor: 1.846

5.  Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).

Authors:  H Pelloux; E Brun; G Vernet; S Marcillat; M Jolivet; D Guergour; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

6.  Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis.

Authors:  José Gutiérrez; María Rodríguez; Gonzalo Piédrola; María del Carmen Maroto
Journal:  Clin Microbiol Infect       Date:  1997-02       Impact factor: 8.067

7.  Application of fluoroimmunoassay to the identification of low avidity specific IgG against pathogenic human viruses and Toxoplasma gondii.

Authors:  F de Ory; I Casas; C J Domingo; J Echevarría
Journal:  Clin Diagn Virol       Date:  1995-05

Review 8.  Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity.

Authors:  Maija Lappalainen; Klaus Hedman
Journal:  Ann Ist Super Sanita       Date:  2004       Impact factor: 1.663

9.  The diagnosis of toxoplasmosis using IgG avidity.

Authors:  R E Holliman; R Raymond; N Renton; J D Johnson
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

10.  Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii.

Authors:  M Gorgievski-Hrisoho; D Germann; L Matter
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  14 in total

1.  Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.

Authors:  M Lefevre-Pettazzoni; A Bissery; M Wallon; G Cozon; F Peyron; M Rabilloud
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling.

Authors:  Jiin Felgner; Silvia Juarez; Chris Hung; L I Liang; Aarti Jain; Mert Döşkaya; Philip L Felgner; Ayşe Caner; Yüksel Gürüz; D Huw Davies
Journal:  Parasitology       Date:  2015-01-14       Impact factor: 3.234

Review 3.  Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature.

Authors:  G Cuomo; V D'Abrosca; V Rizzo; S Nardiello; G La Montagna; G B Gaeta; G Valentini
Journal:  Infection       Date:  2013-04-01       Impact factor: 3.553

4.  Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy.

Authors:  Hossein Elyasi; Jalal Babaie; Hélène Fricker-Hidalgo; Marie-Pierre Brenier-Pinchart; Mehrak Zare; Ghazaleh Sadeghiani; Mehdi Assmar; Hervé Pelloux; Majid Golkar
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

5.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

6.  Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.

Authors:  V Meroni; F Genco; C Tinelli; P Lanzarini; L Bollani; M Stronati; E Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

Review 7.  Diagnosis of toxoplasmosis and typing of Toxoplasma gondii.

Authors:  Quan Liu; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2015-05-28       Impact factor: 3.876

8.  Modification and Evaluation of Avidity IgG Testing for Differentiating of Toxoplasma gondii Infection in Early Stage of Pregnancy.

Authors:  Mohammad Reza Bonyadi; Parvin Bastani
Journal:  Cell J       Date:  2013-08-24       Impact factor: 2.479

9.  The necessity of confirmatory testing in serodiagnosis of toxoplasmosis in iran.

Authors:  Mehrzad Saraei; Seyedeh Zeinab Fattahi; Mojtaba Shahnazi; Afshin Afshari; Safar Ali Alizadeh; Hassan Jahanihashemi
Journal:  Iran J Parasitol       Date:  2013-10       Impact factor: 1.012

10.  Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay.

Authors:  C Vauloup-Fellous; T Lazzarotto; M G Revello; L Grangeot-Keros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.